Medicine and Dentistry
Alpha Adrenergic Receptor
14%
Autoimmune Disease
14%
Autoimmunity
14%
Biological Marker
39%
CA-125
38%
Cancer Diagnosis
28%
Cancer Recurrence
14%
Cancer Risk
14%
Case-Control Study
24%
CD8 Antigen
18%
Cellular Immunity
14%
Cervical Cancer
14%
Diagnostic Test
21%
Flap (Surgery)
66%
Free Tissue Graft
14%
Gastrointestinal Cancer
28%
General Anesthesia
42%
Graft Failure
22%
Gynecology
14%
Herpesviridae
15%
Human Herpesvirus 6
17%
Human Herpesvirus 7
28%
Immune Response
14%
Immunocompetent Cell
28%
Immunotherapy
14%
Infection
40%
Intensive Care
14%
Kidney Concentrating Capacity
14%
Lymphocyte
56%
Lymphocytopenia
27%
Melanoma
71%
Neoplasm
23%
Nutritional Status
14%
Oncolytic Virotherapy
14%
Oncolytic Virus
28%
Ovarian Cancer
100%
Ovarian Tumor
19%
Pelvis
16%
Perioperative Period
14%
Postoperative Complication
32%
Radical Surgery
14%
Reconstructive Surgery
30%
Regional Anesthesia
34%
Retrospective Study
14%
Secretory Protein
39%
Sensitivity and Specificity
14%
Thrombosis
17%
Tumor Antigen
28%
Uterine Cervix
14%
Von Willebrand Factor
14%
Immunology and Microbiology
Adoptive Immunity
14%
Autoimmune Disease
14%
Autoimmunity
14%
Autologous Peripheral Blood Stem Cell Transplantation
14%
Bacteriophage
14%
Betaherpesvirinae
7%
Cancer Staging
7%
CD19
17%
CD25
7%
CD3 Antigen
10%
CD38
14%
CD4
17%
CD4+ T Lymphocyte
7%
CD8
10%
Cellular Distribution
14%
Fibroblast
7%
Free Tissue Graft
14%
Herpesviridae
29%
Human Herpesvirus 6
32%
Human Herpesvirus 7
38%
Immune Response
21%
Immune System
11%
Immunity
10%
Immunity
7%
Immunocompetent Cell
28%
Immunosuppression
5%
Immunosuppressive Drug
16%
Interleukin 6
5%
Leukocyte
5%
Lymphocyte
25%
Lymphocyte Count
17%
Lymphocyte Subpopulation
7%
Lymphocytopenia
15%
Macacine Herpesvirus 1
7%
Macrophage
7%
Natural Killer Cell
10%
Nested Polymerase Chain Reaction
10%
Oncovirus
7%
Peripheral Blood Mononuclear Cell
14%
Polyinosinic:polycytidylic Acid
14%
Pharmacology, Toxicology and Pharmaceutical Science
Alpha Adrenergic Receptor
14%
Alphaherpesvirinae
10%
Apolipoprotein A1
11%
Biological Marker
22%
CA 125 Antigen
11%
Cancer Recurrence
14%
Case-Control Study
20%
Creatinine
11%
Disease
8%
Immunotherapy
14%
Lymphocytopenia
14%
Malignant Neoplasm
14%
Melanoma
14%
Neoplasm
24%
Ovary Cancer
71%
Ovary Tumor
19%
Recurrence Risk
5%
Recurrent Disease
8%
Retrospective Study
14%
Secretory Protein
25%
Transferrin
11%
Transthyretin
11%
Tumor Antigen
14%
Uterine Cervix Cancer
14%
Virotherapy
14%